Cargando…

TGFβ-Treated Placenta-Derived Mesenchymal Stem Cells Selectively Promote Anti-Adipogenesis in Thyroid-Associated Ophthalmopathy

Orbital fibroblasts (OFs) in thyroid-associated ophthalmopathy (TAO) are differentiated from pre-adipocytes and mature adipocytes; increased lipid and fat expansion are the major characteristics of ophthalmic manifestations. Human placental mesenchymal stem cells (hPMSCs) were reported to immunomodu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Hyun-Ah, Park, Mira, Banga, Jasvinder Paul, Lew, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145654/ https://www.ncbi.nlm.nih.gov/pubmed/35628410 http://dx.doi.org/10.3390/ijms23105603

Ejemplares similares

PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves’ ophthalmopathy through SREBP2/HMGCR pathway
por: Park, Mira, et al.
Publicado: (2021)

Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves’ ophthalmopathy
por: Park, Mira, et al.
Publicado: (2019)

Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
por: Kim, Jae Yeon, et al.
Publicado: (2020)

Clinical outcomes of hypofractionated radiotherapy for thyroid-associated ophthalmopathy
por: Lee, Sang Min, et al.
Publicado: (2020)

Treating Thyroid Associated Ophthalmopathy in Pediatric Patients
por: Dong, Tianyu, et al.
Publicado: (2022)

Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy
por: Xiong, Haibo, et al.
Publicado: (2018)

Thyroid-associated Ophthalmopathy
por: Şahlı, Esra, et al.
Publicado: (2017)

Outcome of thyroid associated ophthalmopathy treated by radiation therapy
por: Abboud, Mirna, et al.
Publicado: (2011)

Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy
por: Choi, Seung Woo, et al.
Publicado: (2016)

Cytokines in Thyroid-Associated Ophthalmopathy
por: Zhang, Pengbo, et al.
Publicado: (2022)

Effect of Orbital Decompression on Corneal Topography in Patients with Thyroid Ophthalmopathy
por: Kim, Su Ah, et al.
Publicado: (2015)

Enhanced orbital adipogenesis in a mouse model of T-cell-mediated autoimmunity, zymosan A-treated SKG mice: Implications for Graves’ ophthalmopathy
por: Park, Sera, et al.
Publicado: (2020)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy
por: Huang, Yazhuo, et al.
Publicado: (2018)

Intraorbital Electroacupuncture Therapy for Thyroid-associated Ophthalmopathy
por: Zhou, Ling-Yun, et al.
Publicado: (2017)

Intraorbital Steroid Injection for Active Thyroid Ophthalmopathy
por: Bagheri, Abbas, et al.
Publicado: (2020)

Retinoids Regulate Adipogenesis Involving the TGFβ/SMAD and Wnt/β-Catenin Pathways in Human Bone Marrow Mesenchymal Stem Cells
por: Cao, Jun, et al.
Publicado: (2017)

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy
por: McCorquodale, Tom, et al.
Publicado: (2012)

Research on the Potential Mechanism of Gypenosides on Treating Thyroid-Associated Ophthalmopathy Based on Network Pharmacology
por: Li, Kaijun, et al.
Publicado: (2019)

Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves’ ophthalmopathy patients
por: Shahida, B, et al.
Publicado: (2019)

Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves’ Ophthalmopathy
por: Zhu, Ru, et al.
Publicado: (2023)

Diagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy
por: Savku, Esra, et al.
Publicado: (2015)

Cutting‐edge endonasal surgical approaches to thyroid ophthalmopathy
por: Tyler, Matthew A., et al.
Publicado: (2018)

Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy
por: Smith, Terry J.
Publicado: (2020)

Effect of teprotumumab on intraocular pressure in thyroid-associated ophthalmopathy
por: Adetunji, Modupe O., et al.
Publicado: (2022)

Metformin Attenuates Inflammation and Fibrosis in Thyroid-Associated Ophthalmopathy
por: Xu, Zhihui, et al.
Publicado: (2022)

The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy
por: Huang, Xiao, et al.
Publicado: (2023)

Development of Thyroid-Associated Ophthalmopathy in Patients Who Underwent Total Thyroidectomy
por: Jang, Sun Young, et al.
Publicado: (2015)

Inhibitory Effects of α-Lipoic Acid on Oxidative Stress-Induced Adipogenesis in Orbital Fibroblasts From Patients With Graves Ophthalmopathy
por: Hwang, Sena, et al.
Publicado: (2016)

Inflammatory swelling of the inferior oblique muscle in thyroid associated ophthalmopathy
por: Kakizaki, Hirohiko
Publicado: (2007)

Atypical Presentation of Hashimoto’s Disease in an Adolescent: Thyroid-Associated Ophthalmopathy
por: Kırmızıbekmez, Heves, et al.
Publicado: (2014)

PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy
por: Mou, Pei, et al.
Publicado: (2018)

Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy
por: Higashiyama, Tomoaki, et al.
Publicado: (2018)

Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development
por: Huang, Yazhuo, et al.
Publicado: (2020)

Thyroid-related ophthalmopathy development in concurrence with growth hormone administration
por: Iwata, Shimpei, et al.
Publicado: (2021)

Analysis of macular blood flow changes in thyroid associated ophthalmopathy
por: Zhang, Xiaohan, et al.
Publicado: (2022)

Research progress and application of artificial intelligence in thyroid associated ophthalmopathy
por: Diao, Jiale, et al.
Publicado: (2023)

The efficacy of intensity modulated radiation therapy in treating thyroid-associated ophthalmopathy and predictive factors for treatment response
por: Li, Yong-Jiang, et al.
Publicado: (2017)

Resolution of Pseudoptosis after Anti-inflammatory Treatment of the Contralateral Eye in Thyroid-associated Ophthalmopathy
por: Xu, Dong-Dong, et al.
Publicado: (2016)

Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy
por: Tu, Yunhai, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_937qc8pju1d1l45nsinbbipa54